Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA)

Pediatr Rheumatol Online J. 2014 Jun 11;12:22. doi: 10.1186/1546-0096-12-22. eCollection 2014.

Abstract

Background: Early appearance of antibodies specific for native human type II collagen (anti-CII) characterizes an early inflammatory and destructive phenotype in adults with rheumatoid arthritis (RA). The objective of this study was to investigate the occurrence of anti-CII, IgM RF, IgA RF and anti-CCP in serum samples obtained early after diagnosis, and to relate the occurrence of autoantibodies to outcome after eight years of disease in children with juvenile idiopathic arthritis (JIA).

Methods: The Nordic JIA database prospectively included JIA patients followed for eight years with data on remission and joint damage. From this database, serum samples collected from 192 patients, at a median of four months after disease onset, were analysed for IgG anti-CII, IgM RF, IgA RF and IgG anti-CCP. Joint damage was assessed based on Juvenile Arthritis Damage Index for Articular damage (JADI-A), a validated clinical instrument for joint damage.

Results: Elevated serum levels of anti-CII occurred in 3.1%, IgM RF in 3.6%, IgA RF in 3.1% and anti-CCP in 2.6% of the patients. Occurrence of RF and anti-CCP did to some extent overlap, but rarely with anti-CII. The polyarticular and oligoarticular extended categories were overrepresented in patients with two or more autoantibodies. Anti-CII occurred in younger children, usually without overlap with the other autoantibodies and was associated with high levels of C-reactive protein (CRP) early in the disease course. All four autoantibodies were significantly associated with joint damage, but not with active disease at the eight-year follow up.

Conclusions: Anti-CII, anti-CCP, IgA RF and IgM RF detected early in the disease course predicted joint damage when assessed after eight years of disease. The role of anti-CII in JIA should be further studied.

Keywords: Anti-CCP; Anti-collagen type II antibodies; Arthritis; Child; Joints; Juvenile Idiopathic Arthritis; Rheumatoid factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age of Onset
  • Arthritis, Juvenile* / diagnosis
  • Arthritis, Juvenile* / epidemiology
  • Arthritis, Juvenile* / immunology
  • Arthritis, Rheumatoid* / diagnosis
  • Arthritis, Rheumatoid* / epidemiology
  • Arthritis, Rheumatoid* / immunology
  • Autoantibodies / blood*
  • Biomarkers / blood
  • Child
  • Collagen Type II / immunology*
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin A / blood
  • Immunoglobulin M / blood
  • Male
  • Prognosis
  • Rheumatoid Factor / blood
  • Scandinavian and Nordic Countries / epidemiology

Substances

  • Autoantibodies
  • Biomarkers
  • Collagen Type II
  • Immunoglobulin A
  • Immunoglobulin M
  • Rheumatoid Factor